Skip to main content
uniQure N.V. logo

uniQure N.V. — Investor Relations & Filings

Ticker · QURE ISIN · NL0010696654 LEI · 724500RPCTZLFYJZ3S98 US Manufacturing
Filings indexed 859 across all filing types
Latest filing 2023-02-27 Regulatory Filings
Country NL Netherlands
Listing US QURE

About uniQure N.V.

https://www.uniqure.com/

uniQure N.V. is a gene therapy company focused on developing and commercializing treatments for patients with rare and severe diseases. The company utilizes its adeno-associated virus (AAV) based technology platform to create single-administration therapies with the potential for curative results. Its research and development pipeline is concentrated on liver-directed and central nervous system (CNS) disorders, with a key clinical program targeting Huntington's disease. uniQure aims to deliver transformative medicines by translating scientific innovation into viable treatments.

Recent filings

Filing Released Lang Actions
FORM S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by uniQure N.V. on February 27, 2023. Form S-8 is used to register securities to be offered to employees under employee benefit plans, such as inducement equity awards and stock options. The document includes detailed information about the shares registered, the plans under which they are issued, and legal and procedural undertakings. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration. Therefore, it fits best under the category of Regulatory Filings (RNS).
2023-02-27 English
10-K
Annual Report FY 2022
2023-02-27 English
FORM 4 SUBMISSION
Director's Dealing
2023-02-22 English
FORM 4 SUBMISSION
Director's Dealing
2023-02-22 English
FORM 4 SUBMISSION
Director's Dealing
2023-02-22 English
FORM 4 SUBMISSION
Director's Dealing
2023-02-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.